Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Silvano Garibaldi is active.

Publication


Featured researches published by Silvano Garibaldi.


Nanotechnology | 2006

Carbon nanotube biocompatibility with cardiac muscle cells

Silvano Garibaldi; Claudio Brunelli; Valter Bavastrello; Giorgio Ghigliotti; Claudio Nicolini

Purified carbon nanotubes are new carbon allotropes, sharing similarities with graphite, that have recently been proposed for their potential use with biological systems as probes for in vitro research and for diagnostic and clinical purposes. However the biocompatibility of carbon nanotubes with cells represents an important problem that, so far, remains largely uninvestigated. The objective of this in vitro study is to explore the cytocompatibility properties of purified carbon nanofibres with cardiomyocytes. Cardiac muscle cells from a rat heart cell line H9c2 (2-1) have been used. Highly purified single-walled nanotubes (SWNTs) were suspended at the concentration of 0.2 mg ml−1 by ultrasound in complete Dulbeccos modified Eagles medium, and administered to cells to evaluate cell proliferation and shape changes by light microscopy, cell viability by trypan blue exclusion, and apoptosis, determined flow cytometrically by annexin/PI staining. Microscopic observation evidenced that carbon nanotubes bind to the cell membrane, causing a slight modification in cell shape and in cell count only after three days of treatment. Cell viability was not affected by carbon nanotubes in the first three days of culture, while after this time, cell death was slightly higher in nanotube-treated cells (p = ns). Accordingly, nanotube treatment induced little and non-significant change in the apoptotic cell number at day 1 and 3. The effect of nanotubes bound to cells was tested by reseeding treated cardiomyocytes. Cells from a trypsinized nanotube-treated sample showed a limited ability to proliferate, and a definite difference in shape, with a high degree of cell death: compared to reseeded untreated ones, in SWNT-treated samples the annexin-positive/PI-negative cells increased from 2.9% to 9.3% in SWNT (p<0.05, where p<0.05 defines a statistically significant difference with a probability above 95%), and the annexin-positive/PI-positive cells increased from 5.2% to 18.7% (p<0.05). However, overtime cells from a trypsinized nanotube-treated sample continued to grow, and partially recovered the original shape. In conclusion our results demonstrate that highly purified carbon nanotubes possess no evident short-term toxicity and can be considered biocompatible with cardiomyocytes in culture, while the long-term negative effects, that are evidenced after reseeding, are probably due to physical rather than chemical interactions.


American Journal of Physiology-heart and Circulatory Physiology | 2009

Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2

Paolo Spallarossa; Paola Altieri; Concetta Aloi; Silvano Garibaldi; Chiara Barisione; Giorgio Ghigliotti; Giuseppina Fugazza; Antonio Barsotti; Claudio Brunelli

Low or high doses of doxorubicin induce either senescence or apoptosis, respectively, in cardiomyocytes. The mechanism by which different doses of doxorubicin may induce different stress-response cellular programs is not well understood. A recent study showed that the level of telomere dysfunction may induce senescence or apoptosis. We investigated the pathways to both apoptosis and senescence in neonatal rat cardiomyocytes and in H9c2 cells exposed to a single pulsed incubation with low or high doses of doxorubicin. High-dose doxorubicin strongly reduces TRF2 expression while enhancing TRF1 expression, and it determines early apoptosis. Low-dose doxorubicin induces downregulation of both TRF2 and TRF1, and it also increases the senescence-associated-beta-galactosidase activity, downregulates the checkpoint kinase Chk2, induces chromosomal abnormalities, and alters the cell cycle. The involvement of TRF1 and TRF2 with apoptosis and senescence was assessed by short interfering RNA interference. The cells maintain telomere dysfunction and a senescent phenotype over time and undergo late death. The increase in the phase>4N and the presence of micronuclei and anaphase bridges indicate that cells die by mitotic catastrophe. p38 modulates TRF2 expression, whereas JNK and cytoplasmic p53 regulate TRF1. Pretreatment with specific inhibitors of MAPKs and p53 may either attenuate the damage induced by doxorubicin or shift the cellular response to stress from senescence to apoptosis. In conclusion, various doses of doxorubicin induce differential regulation of TRF1 and TRF2 through p53 and MAPK, which is responsible for inducing either early apoptosis or senescence and late death due to mitotic catastrophe.


Inflammation | 2014

Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

Giorgio Ghigliotti; Chiara Barisione; Silvano Garibaldi; Patrizia Fabbi; Claudio Brunelli; Paolo Spallarossa; Paola Altieri; Gianmarco Rosa; Giovanni Spinella; Domenico Palombo; Razvan Arsenescu; Violeta Arsenescu

Adipose tissue inflammation mediates the association between excessive body fat accumulation and several chronic inflammatory diseases. A high prevalence of obesity-associated adipose tissue inflammation was observed not only in patients with cardiovascular conditions but also in patients with inflammatory bowel diseases, abdominal aortic aneurysm, or cardiorenal syndrome. In addition to excessive caloric intake, other triggers promote visceral adipose tissue inflammation followed by chronic, low-grade systemic inflammation. The infiltration and accumulation of immune cells in the inflamed and hypertrophied adipose tissue promote the production of inflammatory cytokines, contributing to target organ damages. This comorbidity seems to delimit subgroups of individuals with systemic adipose tissue inflammation and more severe chronic inflammatory diseases that are refractory to conventional treatment. This review highlights the association between adipose tissue immune response and the pathophysiology of visceral adiposity-related chronic inflammatory diseases, while suggesting several new therapeutic strategies.


Acta Diabetologica | 1999

Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects.

Patrizio Odetti; Silvano Garibaldi; G. Noberasco; Irene Aragno; Sabina Valentini; Nicola Traverso; Umberto M. Marinari

Abstract Carbonyl groups result from protein oxidation and their level in tissues and plasma is a relatively stable marker of oxidative damage. Carbonyl content of plasma proteins in 43 type 2 diabetic subjects, 30–87 years of age (25 males and 18 females) and in 20 age-matched healthy controls (31–89 years of age, 12 males and 8 females) was evaluated with 2,4-dinitro-phenyl-hydrazine method. In both groups, lipids, tocopherols (HPLC) and glycated hemoglobin (HPLC) were studied.Fasting blood glucose, glycated hemoglobin and lipids were significantly higher in the diabetic group; carbonyl content and α-tocopherol were slightly, but not significantly higher in the diabetic group (1.06 ± 0.03 vs. 0.97 ± 0.04 nmol/mg protein, 27.07 ± 2.82 vs. 31.55 ± 2.11 μmol/l, respectively). Significant relationships between age and lipids, α-tocopherol and proteins were found in controls, but not in diabetics. Alpha-tocopherol correlated with lipids in both groups; glycated hemoglobin, a marker of glycemic control, was related to lipids, α-tocopherol and protein carbonyl groups in diabetics, while only the correlation with carbonyls was found in controls.These results suggest that impaired glycemic control is connected to protein oxidation. Glycation cascade also releases free radicals, becoming responsible for further oxidative attacks. In conclusion, increased oxidative stress, if any, in the diabetic group, is doubtlessly induced by hyperglycemia, and the tocopherols are not seriously affected by a worsening of the metabolic control.


Disease Markers | 2010

CD14CD16 Monocyte Subset Levels in Heart Failure Patients

Chiara Barisione; Silvano Garibaldi; Giorgio Ghigliotti; Patrizia Fabbi; Paola Altieri; Maria Carla Casale; Paolo Spallarossa; Giovanni Bertero; Manrico Balbi; Luca Corsiglia; Claudio Brunelli

Our aim was to define the distribution of monocyte subsets in a cohort of congestive heart failure (CHF) patients, to verify whether increased severity of CHF is linked to the expansion of specific monocyte subsets, and finally to investigate the relationship between monocyte subset relative frequencies, laboratory parameters of inflammation, and monocyte ACE expression. Thirty consecutive CHF patients and 26 healthy control subjects were evaluated for peripheral blood monocyte expression of CD14, CD16 and CD143 (ACE) by flow-cytometry, and for endothelial-derived soluble CD146 levels by ELISA. CD14++CD16+ frequency was significantly higher in CHF patients than in Controls (%, median value and IQ) (12.3, 8.7–14.8 vs 5.9, 4.7–6.9, p++CD16+ levels. Frequencies of CD14+CD16+ monocytes were significantly lower in CHF patients as compared to Controls, and negatively correlated with levels of soluble CD146 (r = −0.529; p 0.048). In conclusion, monocytic CD14++CD16+ frequency and CD143 levels are increased and reflect disease status and progressive cardiac deterioration in CHF patients. The CD14+CD16+ subset is depleted in CHF and is linked to endothelial damage in this group of patients. Although the question of whether differences in monocyte CD14CD16 expansion are causal or whether they represent a marker of HF progression which is potentially relevant for risk prediction remains unanswered, we believe that our data represent an important tool for exploring the role of selective inflammatory pathways in CHF progression.


Journal of Surgical Research | 2011

Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development

Daniela Palmieri; Bianca Pane; Chiara Barisione; Giovanni Spinella; Silvano Garibaldi; Giorgio Ghigliotti; Claudio Brunelli; Ezio Fulcheri; Domenico Palombo

BACKGROUND Monocyte activation, macrophage infiltration, vascular oxidative stress and matrix proteolysis are inflammatory key steps contributing to abdominal aortic aneurysm (AAA) development. A phenotypical and functional heterogeneity is recognizable in monocytes by the differential expression of surface molecules: CD62L- subset corresponds to activated monocytes, while CD143/ACE surface expression increases during their differentiation into macrophages. In this work, Resveratrol, which is an antioxidant polyphenol with vasoprotective properties, has been evaluated for its potential to limit aneurysm development and monocyte-dependent inflammatory response in a model of elastase-induced AAA. METHODS Male Sprague-Dawley rats received Resveratrol (10 mg/kg/die) (Rsv group, n=15) or vehicle (ethanol) alone (Et-OH group, n=15) continuously from 7 d before until 14 d after the AAA induction with elastase; five littermates were used as untreated control group (Ctr group, n=5). At the end of treatment, CD143 and CD62L monocyte expression was analyzed by flow cytometry, serum antioxidant capacity was evaluated using the TRAP method and circulating TNFα, and MMP-9 were measured with ELISA and gel zymography, respectively. Aortas were subjected to histology and immunohistochemistry for morphological analysis, macrophage infiltration, and MMP-9, TNFα, and VEGF expression. RESULTS Resveratrol counteracted the CD62L-monocyte subset expansion, CD143 monocyte expression, and circulating levels of MMP-9 activity and TNFα associated to AAA induction. Similarly, treatment with Resveratrol significantly attenuated AAA expansion, vessel wall macrophage infiltration and MMP-9, VEGF, and TNFα expression, compared with AAA from Et-OH group. CONCLUSIONS Resveratrol limited the monocyte-dependent inflammatory response, macrophage differentiation and aortic lumen enlargement in elastase-induced AAA. These data suggest that Resveratrol might be tested in selected patients with small AAA to modulate the early systemic and local inflammatory response associated to AAA progression.


Diabetes-metabolism Research and Reviews | 2000

Scanning force microscopy reveals structural alterations in diabetic rat collagen fibrils: role of protein glycation

Patrizio Odetti; Irene Aragno; R. Rolandi; Silvano Garibaldi; Sabina Valentini; L. Cosso; Nicola Traverso; Damiano Cottalasso; Maria Adelaide Pronzato; Umberto M. Marinari

The main functional property of collagen is to provide a supporting framework to almost all tissues: the effects of non‐enzymatic glycation on this protein are deleterious and in diabetes mellitus contribute to the mechanism of late complications. The aim of this work is to provide evidence by scanning force microscopy of modifications in collagen structure caused by high glucose concentration, in vivo and in vitro, and to correlate the data with markers of non‐enzymatic glycation.


Free Radical Research | 1998

Oxidative stress in subjects affected by celiac disease

Patrizio Odetti; Sabina Valentini; Irene Aragno; Silvano Garibaldi; Maria Adelaide Pronzato; E. Rolandi; T. Barreca

In order to study the role of oxidative stress in celiac disease, protein carbonyl groups, thiobarbituric acid-reactive substance and pentosidine were evaluated in the plasma of nine patients with asymptomatic celiac disease and in a control group (n = 25). Plasma alpha-tocopherol, retinol and lipids were determined in the same samples. The levels of markers of oxidative stress derived from both protein (carbonyl groups) and lipids (thiobarbituric acid-reactive substances) were significantly higher in celiac disease patients, whereas lipoproteins and alpha-tocopherol were significantly lower. These data indicate that in celiac disease, even when asymptomatic, a redox imbalance persists; this is probably caused by an absorption deficiency, even if slight. Dietary supplementation with antioxidant molecules may offer some benefit and deserves further investigation.


Disease Markers | 2006

C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians.

Sabina Nasti; Paolo Spallarossa; Paola Altieri; Silvano Garibaldi; Patrizia Fabbi; Luisa Polito; Luca Bacino; Michele Brunelli; Claudio Brunelli; Antonio Barsotti; Giorgio Ghigliotti

Background: specific polymorphisms of genes regulating intracellular redox balance and oxidative stress are related to atherogenesis. Some studies have identified a relationship between progression of atherosclerosis and C242T mutation in CYBA gene coding for p22phox, a subunit of the NADH/NADPH oxidase system. Design: we investigated whether the C242T nucleotide transition is associated with the presence of coronary artery disease (CAD) in a population of 494 Caucasian Italians undergoing coronary angiography to diagnose the cause of chest pain. Results: the frequency of the T mutant allele that we found in 276 patients with angiographically documented CAD was significantly higher compared to what we observed in 218 subjects with normal coronary arteries (Controls) (respectively: 0.400 and 0.332, p < 0.01). The prevalence of the T allele was even stronger when we compared: 1) early onset (age ≤55) vs late onset (age ≥65) single-vessel CAD patients (respectively: 0.75 and 0.48, p < 0.05), and 2) the subgroup of CAD patients with at least one ≥98% stenosis in a coronary vessel vs those with no ≥98% stenosis in a coronary vessel (respectively: 0.425 and 0.365, p < 0.05). Conclusions: these results support the increased risk of developing early CAD and of having rapid progression of coronary stenosis in subjects carrying the C242T nucleotide transition among the Italian population.


Atherosclerosis | 2008

Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity

Paolo Spallarossa; Silvano Garibaldi; Chiara Barisione; Giorgio Ghigliotti; Paola Altieri; Irene Tracchi; Patrizia Fabbi; Antonio Barsotti; Claudio Brunelli

Postprandial state is a pro-inflammatory condition associated with a transient impairment of endothelial function. Recent evidence suggests that myeloperoxidase (MPO) and matrix metalloproteinase-9 (MMP-9) are involved in the pathogenesis of inflammatory vascular diseases such as atherosclerosis. The present study was carried out to investigate whether a fat meal induces polymorphonuclear (PMN) activation and increases the plasma activity of MPO and MMP-9 and whether postprandial serum exerts pro-apoptotic effects on endothelial cells. Fifteen healthy young men underwent a high-fat challenge containing 60g butter. Blood samples were drawn before, and 1, 2, and 4h after the meal. Leukocyte reactive oxygen species (ROS) production, plasma MPO and MMP-9 activity, endothelial-derived soluble CD146 levels, and advanced oxidation protein product (AOPP) levels were determined. Human umbilical vein endothelial cells (HUVECs) were treated with human sera to evaluate mitochondrial membrane potential, ROS production, annexin PI staining, and caspase-3 activity. Triglycerides, ROS production, MPO activity, AOPP levels, pro-MMP-9 zymographic activity, and soluble CD146 levels significantly increased during the 4h after the test meal. Postprandial serum significantly decreased the mitochondrial membrane potential, and increased the rate of ROS production, the percentage of annexin-positive HUVECs, and caspase-3 activity. A strong relationship was observed between postprandial increase in PMN-derived MPO and pro-MMP-9 activity, and the increased rate of apoptosis of endothelial cells exposed to postprandial serum. Data show that postprandial serum exerts pro-apoptotic effects on endothelial cells. The close relationships between markers of endothelial cell apoptosis and MPO and pro-MMP-9 activity suggest that the latter may contribute to the development of fat meal induced endothelial damage.

Collaboration


Dive into the Silvano Garibaldi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge